Výsledky vyhledávání

Nalezeno záznamů: 106  
Váš dotaz: Autor = ("petrak")
  1. 1.
    HRDINOVA, T.G; TOMAN, O.; DRESLER, J.; KLIMENTOVA, J.; SALOVSKA, B.; PAJER, P.; BARTOS, O.; POLIVKOVA, V.; LINHARTOVA, J.; MACHOVA POLAKOVA, K.; KABICKOVA, H.; BRODSKA, B.; KRIJT, M.; ZIVNY, J.; VYORAL, D.; PETRAK, J.G Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib. International journal of oncology. 2021, vol. 58, no. 2, s. 238-250. ISSN 1019-6439.
  2. 2.
    HAVLENOVA, T.; PETRAK, J.; KRIJT, M.; BEHOUNEK, M.; FRANEKOVA, J.; CERVENKA, L.; PLUHACEK, T.; VYORAL, D.; MELENOVSKY, V. Myocardial iron homeostasis and hepcidin expression in a rat model of chronic heart failure at different levels of dietary iron intake. European journal of heart failure. 2019, vol. 21, no. S1, abstr. no. P2206. ISSN 1388-9842.
  3. 3.
    PETRAK, J.; HAVLENOVA, T.; KRIJT, M.; BEHOUNEK, M.; FRANEKOVA, J.; CERVENKA, L.; PLUHACEK, T.; VYORAL, D.; MELENOVSKY, V. Myocardial iron homeostasis and hepcidin expression in a rat model of heart failure at different levels of dietary iron intake. Biochimica et biophysica acta: general subjects. 2019, vol. 1863, no. 4, s. 703-713. ISSN 0304-4165.
  4. 4.
    KRIJT, M.; BEHOUNEK, M.; VYORAL, D.; MELENOVSKY, V.; PETRAK, J. Chronic heart failure dysregulates mRNA expression of iron-related genes in rat hearts. [Prezentováno: The European iron club meeting. Zürich, 8.2.-11.2.2018.].
  5. 5.
    KRIJT, M.; JIRKOVSKA, A.; KABICKOVA, T.; MELENOVSKY, V.; PETRAK, J.; VYORAL, D.G Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using 55Fe and storage phosphorimaging. Biochimica et biophysica acta: general subjects. 2018, vol. 1862, no. 12, s. 2895-2901. ISSN 0304-4165.
  6. 6.
    VYORAL, D.G; PETRAK, J. Therapeutic potential of hepcidin: the master regulator of iron metabolism. Pharmacological research. 2017, vol. 115, no. 1, s. 242-254. ISSN 1043-6618.
  7. 7.
    KRIJT, M.; PETRAK, J.; MELENOVSKY, J.; VYORAL, D. Cardiomyocyte iron-ome studied by metabolic labelling by 55Fe followed by native electrophoresis and phosphorimager detection. [Prezentováno: The annual meeting of the European Iron Club (EIC) 2016. Innsbruck, 7.4.-10.4.2016.].
  8. 8.
    TOMAN, O.G; KABICKOVA, T.; VIT, O.; FISER, R.; MACHOVA POLAKOVA, K.; ZACH, J.; LINHARTOVA, J.; VYORAL, D.; PETRAK, J. Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target. Oncology reports. 2016, vol. 36, no. 3, s. 1258-1268. ISSN 1021-335X.
  9. 9.
    LORKOVA, L.; SCIGELOVA, M.; ARREY, T.N.; VIT, O.; POSPISILOVA, J.; KLANOVA, M.; ALAM, M. ; VOCKOVA, P.; MASWABI, B.; KLENER, P. JR.; PETRAK, J. Detailed functional and proteomic characterization of fludarabine resistance in mantle cell lymphoma cells. PLoS one [online]. 2015, vol. 10, no. 8, art. no. e0135314 [cit. 2015-09-21]. ISSN 1932-6203. Dostupný z WWW: <http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0135314>.
  10. 10.
    KLANOVA, M.; LORKOVA, L.; VIT, O.; MASWABI, B.; MOLINSKY, J.; POSPISILOVA, J.; VOCKOVA, P.; MAVIS, C.; LATECKOVA, L.; KULVAIT, V.; VEJMELKOVA, D.; JAKSA, R.; HERNANDEZ, F.; TRNENY, M.; VOKURKA, M.; PETRAK, J.; KLENER, P. JR. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents. Molecular cancer [online]. 2014, vol. 13, no. 1, art. no. 159 [cit. 2014-07-28]. ISSN 1476-4598. Dostupný z WWW: <http://www.molecular-cancer.com/content/13/1/159>.

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.

Přijmout všeNastaveníOdmítnout vše